gallbladder 3: 46
gastrointestinal system 3: 1
glucagon 3: 128
graft vs. host disease 2: 263
heavy-metal poisoning 4: 31
hematopoiesis 2: 140
hemochromatosis 3: 133
hepatic abscess 3: 54
hepatitis 3: 54
hepatomegaly 3: 57
hepatotoxins 3: 57
immune system 2: 235
ingested toxins 4: 384
insulin 3: 148
islets of Langerhans 3: 149
jaundice 3: 67
liver cancer 3: 69
liver failure 3: 72
malaria 2:342, 343
medicinal herbs and botanicals
4: 83
milk thistle 4: 89
neonatal jaundice 3: 306
obesity and cardiovascular
disease 2: 90
organ transplantation 4: 270
peptic ulcer disease 3: 82
porphyria 4: 138
portal hypertension 3: 83
primary biliary cirrhosis 3: 84
renin 3: 158
rickets 4: 199
steatohepatitis 3: 89
triglyceride blood level 2: 112
triglycerides, dietary 4: 202
Wilson’s disease 3: 167
Zollinger-Ellison syndrome 3: 94
liver cancer 2:327, 370, 373; 3: 55 ,
69–71, 70 t, 340
liver disease 3:57, 73, 84, 200;
4:319, 351
liver disease of alcoholism 3:16, 57,
71–72,90; 4:89, 317
liver enzymes 3:57, 73, 74
liver failure 1:368; 3:72–73, 72 t
alcohol interactions with
medications 4: 319
bioavailability 4: 153
cirrhosis 3: 24
dextromethorphan 4: 332
esophageal varices 3: 42
hemochromatosis 3: 133
hepatitis 3:54, 56
hepatitis prevention 4: 32
hepatorenal failure 3: 195
hepatotoxins 3: 57
liver disease of alcoholism 3: 72
liver hemodialysis 3: 75
liver transplantation 3: 75
overdose 4:165–166
portal hypertension 3: 84
primary biliary cirrhosis 3: 84
primary sclerosing cholangitis
3: 85
short bowel syndrome 3: 88
liver function tests 3: 73 , 73–75,
74 t,82, 84, 89
liver hemodialysis 3:75
liver spots. Seelentigines
liver transplantation 3:75–76, 76 t
biliary atresia 3: 19
cirrhosis 3: 25
esophageal varices 3: 42
gastrointestinal system 3: 6
hepatitis prevention 4: 32
hepatorenal failure 3: 195
liver disease of alcoholism 3: 72
liver failure 3: 73
overdose 4: 166
portal hypertension 3: 84
primary biliary cirrhosis 3: 84
primary sclerosing cholangitis
3: 85
livestock 2:309–311, 338
living donor transplantation 3:75,
187, 200, 206
living organ donation 4:270, 271
living with allergies 2:247–248,
258 , 279–280
living with cardiovascular disease
2: 5 , 73–74, 104
living with chronic pulmonary
conditions 2:185, 190, 201, 203,
205 , 207–208
living with immune disorders
2:280
living with pain 1:378
LMWH. Seelow molecular weight
heparin
lobes, of cerebral cortex 1:231,
231 t,242, 243t
lobular capillary hemangioma. See
granuloma telangiectaticum
lobules 3:69, 83, 250
location, sense of. See
proprioception
locus 4:113, 119, 127
long bones 1:308, 309, 341
long QT syndrome (LQTS) 2:7, 19,
39, 40, 74–75, 111
loop diuretics 2:80–81, 81t
lordosis 1: 298 , 334Lou Gehrig’s disease. See
amyotrophic lateral sclerosis
low-density lipoprotein (LDL) 2:16,
36, 66; 4:98, 202
low-density lipoprotein cholesterol
(LDL-C)
apoB100 2: 16
cholesterol blood levels 2:36–37
diabetes and cardiovascular
disease 2:48–49
diet and cardiovascular health
2: 50
hyperlipidemia 2: 65
medications to treat
cardiovascular disease 2: 82
omega fatty acids and
cardiovascular health 2: 90
soy and cardiovascular health
2: 106
triglyceride blood level 2: 112
low molecular weight heparin
(LMWH) 2:14, 78
LQTS. Seelong QT syndrome
lumbar puncture 1: 241 , 259;
2:323, 341, 344
lumbar spine 1:306, 334, 354
lung abscess 2:208, 232
lung cancer 2:208–212, 209 t, 210 ,
211 t
addiction 4: 314
adult survivors of childhood
cancer 2: 367
antismoking efforts 4: 8
asbestosis 2:184, 185
atelectasis 2: 191
bronchitis 2: 196
cancer vaccines 2: 373
cannabis 4: 327
CEA 2: 374
lifestyle variables: smoking and
obesity 4: 282
pleural effusion 2: 218
radon exposure 4: 43
smoking and cancer 2: 392
smoking and health 4:303, 304
smoking and pulmonary disease
2:230, 231
thoracentesis 2: 232
thoracotomy 2: 232
tobacco 4: 353
tobacco use other than smoking
4: 306
lung capacity 2:73, 182
lungs 1:168; 2:212–213, 212 t–213t
aerobic capacity 4: 213
aerobic exercise 4: 214Index 485